THRIVE study protocol: a randomized controlled trial evaluating a web-based app and tailored messages to improve adherence to adjuvant endocrine therapy among women with breast cancer

• Egile Nagusiak: Andrew J. Paladino (Egilea), Janeane N. Anderson (Egilea), Rebecca A. Krukowski (Egilea), Teresa Waters (Egilea), Mehmet Kocak (Egilea), Carolyn Graff (Egilea), Ryan Blue (Egilea), Tameka N. Jones (Egilea), Joanne Buzaglo (Egilea), Gregory Vidal (Egilea), Lee Schwartzberg (Egilea), Ilana Graetz (Egilea)
• Formatua: Liburua
• Argitaratua: BMC, 2019-12-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Abstract Background Long-term use of adjuvant endocrine therapy (AET) among women with early-stage, hormone receptor-positive breast cancer significantly reduces the risk of hospitalizations, cancer recurrence, and mortality. AET is associated with adverse symptoms that often result in poor adherenc...